Literature DB >> 7620105

Portal blood flow in acute hepatitis with and without ascites: a non-invasive measurement using an ultrasonic Doppler.

S S Yang1, C H Wu, T K Chen, C L Lee, Y C Lai, D S Chen.   

Abstract

To evaluate the role of portal blood flow in severe acute hepatitis leading to the formation of ascites, we studied the portal blood flow of 30 patients with severe acute hepatitis (20 without ascites and 10 with ascites), 20 patients with mild acute hepatitis and 20 healthy normal volunteers using duplex sonography. The portal blood flow of patients with severe acute hepatitis and ascites (421 +/- 94 mL/min) was lower than that of the volunteers (725 +/- 131 mL/min), the mild acute hepatitis (658 +/- 148 mL/min), and the severe acute hepatitis (633 +/- 108mL/min) without ascites (P < 0.001). The congestion index of severe acute hepatitis and ascites (0.16 +/- 0.04 cm.s) was higher than that of the volunteers (0.09 +/- 0.03 cm.s, P < 0.001), the mild acute hepatitis (0.09 +/- 0.02 cm.s, P < 0.001), and the severe acute hepatitis (0.12 +/- 0.04 cm.s, P < 0.02) without ascites. Portal blood flow was negatively correlated with prolonged prothrombin time (P < 0.001) and serum total bilirubin level (P = 0.002) and congestion index was positively correlated with heart rate (P = 0.006), prolonged prothrombin time (P < 0.001) and serum total bilirubin level (P = 0.001). Our study shows that in severe acute hepatitis, portal blood flow was reduced in patients with ascites. The non-invasive ultrasonic Doppler is a safe and helpful method in the clinical evaluation of portal hypertension in severe acute hepatitis.

Entities:  

Mesh:

Year:  1995        PMID: 7620105     DOI: 10.1111/j.1440-1746.1995.tb01044.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  8 in total

1.  Portal hemodynamics in fulminant hepatic failure as assessed by duplex Doppler ultrasonography.

Authors:  Y Chawla; A Sreedharan; R K Dhiman; S Jain; S Suri
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

2.  Clinical and histological recovery from "life-threatening" severe acute alcoholic hepatic failure with complete hepatofugal portal blood flow.

Authors:  Keiichi Fujiwara; Takeshi Toriyabe; Yoshihiro Fukuda; Osamu Yokosuka
Journal:  Clin J Gastroenterol       Date:  2010-12-10

3.  Elevated resistive index in the hepatic artery as a predictor of fulminant hepatic failure in patients with acute viral hepatitis: a prospective study using Doppler ultrasound.

Authors:  Katsuaki Tanaka; Kazushi Numata; Manabu Morimoto; Kazuhito Shirato; Satoru Saito; Toshio Imada; Shinju Arata; Mitsugi Sugiyama
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

4.  Portalsystemic hemodynamic changes in chronic severe hepatitis B: An ultrasonographic study.

Authors:  Zhong-Zhen Su; Hong Shan; Wei-Min Ke; Bing-Jun He; Rong-Qin Zheng
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

5.  Percentage of peak-to-peak pulsatility of portal blood flow can predict right-sided congestive heart failure.

Authors:  Jui-Ting Hu; Sien-Sing Yang; Yun-Chih Lai; Cheng-Yen Shih; Cheng-Wen Chang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

6.  Liver fibrosis in chronic viral hepatitis: an ultrasonographic study.

Authors:  Rong-Qin Zheng; Qing-Hui Wang; Ming-De Lu; Shi-Bin Xie; Jie Ren; Zhong-Zhen Su; Yin-Ke Cai; Ji-Lu Yao
Journal:  World J Gastroenterol       Date:  2003-11       Impact factor: 5.742

7.  Regorafenib could cause sinusoidal obstruction syndrome.

Authors:  Motoi Takahashi; Shigeru Harada; Hideo Suzuki; Naoki Yamashita; Hiroyuki Orita; Masaki Kato; Kazuhiro Kotoh
Journal:  J Gastrointest Oncol       Date:  2016-06

8.  Long-term Nucleos(t)ides Analogues for Chronic Hepatitis B Improve Liver and Spleen Size: A Noninvasive Sonographic Study.

Authors:  Ruei-Hsin Chang; Tsolmon Nyamsuren; Sarvesh Gyawali; Szu-Chieh Fu; Yi-Wen Huang; Rui-Ting Hu; Sien-Sing Yang
Journal:  J Med Ultrasound       Date:  2017-05-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.